Concerns Regarding Opening a Supervised Injection Site in San Francisco In January 2023, the Executive Director of New York’s OnPoint testified to San Francisco’s Board…
Concerns Regarding Opening a Supervised Injection Site in San Francisco In January 2023, the Executive Director of New York’s OnPoint testified to San Francisco’s Board…